We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues 48 Product-Specific Bioequivalence Guidances
FDA Issues 48 Product-Specific Bioequivalence Guidances
September 25, 2012
The FDA has issued dozens of draft and revised draft product-specific guidances that detail its recommendations for bioequivalence (BE) studies to support ANDAs.